A Complete Response Letter (CRL) from the FDA due to manufacturing issues can destroy a biotech. CEO Ron Cooper warns leaders to invest heavily in Chemistry, Manufacturing, and Controls (CMC) early, even when the cost exceeds the clinical trial spend. This early investment in professionalizing CMC is critical to de-risk the company's future.

Large companies often identify an opportunity, create a solution based on an unproven assumption, and ship it without validating market demand. This leads to costly failures when the product doesn't solve a real user need, wasting millions of dollars and significant time.

A structured, three-stage validation protocol can test raffinose in just eight weeks. It progresses from a 96-well plate screen to spin tubes to benchtop bioreactors. Each stage has a clear go/no-go criterion, allowing teams to quickly determine viability for their process without over-investing resources.

Contrary to typical agile discovery, projects in high-stakes environments benefit from starting with extremely strict processes and documentation. This establishes a compliant foundation. Flexibility can be introduced later, once core requirements and constraints are fully mastered, rather than starting loose and adding rigor.

Instead of immediately scaling up the manufacturing process between clinical Phase 1 and 2, it is strategically better to produce more batches using the established Phase 1 process. This approach builds critical knowledge about process parameters and CQAs through repetition and increased clinical exposure.

A drug's manufacturing process is not static. Over a 10-20 year lifecycle, it will inevitably change due to raw material shifts or optimizations. Therefore, continued verification (PV Stage 3) is crucial for actively managing these expected deviations to maintain a state of control, not just for passive monitoring.

Getting approval for an operations hire is difficult because they aren't directly tied to new revenue. Instead of a vague promise of "efficiency," build a business case by quantifying the cost of a broken process—like a high lead disqualification rate—and show how the hire will unlock that hidden pipeline.

When stakeholders want to ship a high-fidelity prototype immediately, counter by explaining the required effort using numbers. Frame the work in terms of scale (e.g., "This must support 200 products, each requiring a week of testing") to manage expectations and justify proper engineering.

Stop thinking of validation as a one-time step before you build. True validation is an ongoing process that applies to every business decision, from adding a feature to launching a new marketing channel. You are constantly validating until you sell the company.